Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules
Executive Summary
An FDA "untitled" letter to Pfizer on Celebrex and Bextra is the agency's second recent objection to the company's interpretation of the boundaries of "reminder" ads